J&J calls £1.7bn global creative review

Johnson & Johnson, the health and skincare company, has triggered a review of its $2.6bn (£1.7bn) global creative business held by a number of rival networks.

No Responses to “J&J calls £1.7bn global creative review”

Post a Comment